Desperate Hacker

Chapter 617 Market Value Management

"Old Chen, the suggestion given by Sun Pharmaceutical is that if the new technology is indeed feasible and passes clinical verification, then Sun Pharmaceutical will achieve a growth of more than 70% every year!"

"what?"

"The new growth areas are mainly concentrated in the field of traditional diabetes treatment drugs. Of course, all this depends on the results of the third phase of clinical trials. In short, as long as the results of Professor Yamanaka's research can be transformed into new technologies for clinical use, then Not surprisingly, Sun Pharmaceuticals will become the most dazzling pharmaceutical giant in Asia. By the way, there is also good news, that is, the new antibiotics have been confirmed to be theoretically harmless to the human body. We are currently looking for suitable samples to take a look. The clinical therapeutic effect of this drug on recalcitrant drug-resistant bacteria..."

Zhou Yaojie summarized the future development of the group company to Chen Qingfeng.

To be honest, Chen Qingfeng originally took so much money to invest in cancer research funds.

Zhou Yaojie actually felt a little reluctant to part with it.

But over the years, he has experienced so many things with Chen Qingfeng.

I know it’s not easy for Lao Chen to hold on until now.

Besides, Zhou Yaojie doesn't have to worry about food and drink now, and he has saved enough money to spend in a lifetime, so why should he worry about Chen Qingfeng's life-saving money.

What followed was a huge response reflected in the framework of Sun Pharmaceuticals.

You must know that Professor Yamanaka is an authority in the field of stem cells. The research and results he has conducted are not papers published casually by universities whose names have not even been heard of in China.

But even so, this is still a happy event.

This wealth on paper is now actually owned by Evergreen Technology in Malaysia.

Zhou Yaojie, a top business school graduate, immediately sensed a difference.

But at the beginning, Professor Yamanaka encountered a cold reception. In Japan, at academic conferences, Professor Yamanaka encountered backstabbing from his own students and bureaucrats from the Ministry of Economy, Trade and Industry. It is said that many of his research in Japan were immediately stopped from aid.

The Indian business community quickly learned about the two heavyweight achievements and chose to cooperate with Sun Pharmaceuticals. Clinical trials have now begun in India.

However, Adani knew in his heart that he was only the agent of Taiyang Pharmaceutical, so he was just a passing god of wealth.

The subversion of his research is that once the results are implemented, it means that diabetes can be cured, rather than a disease that can only be maintained by drugs.

We cannot say that Professor Yamanaka is 100% safe from fraud.

This means that all the drug and pharmaceutical giants in the world currently involved in this field will have their business taken away by their Sun Pharmaceuticals.

For several consecutive trading days, Sun Pharma’s share price continued to rise, so much so that in just one week, Sun Pharma’s share price surpassed the combined share prices of all Indian generic drug giants.

But as two Chinese and American research institutions successively released some research results.

Suddenly, the share price of Adani Group also began to trend upward.

However, since people can produce Nobel Prize-level results, they have also been verified around the world.

The reason is simple. Both studies are enough to subvert some of the inherent business logic of the current pharmaceutical industry.

As for the domestic side, the experts invited for inspection and acceptance criticized it vigorously. It is said that the application for clinical trials also seemed to be opposed by many experts.

Fortunately, the sky is the limit, and Chen Qingfeng made arrangements for Sun Pharmaceuticals early. Originally, this step was not very profitable, but now there is an unexpected surprise.

That at least shows that his ability and level, as well as his past integrity, are enough to be believed.

The rise in stock prices alleviates the problem of capital.

At the same time, it means that Adani can have more funds to help his sponsors behind the scenes to sort out the mess caused by the current acquisition of military industrial enterprises.

However, Sun Pharmaceutical's surprise came too suddenly and attracted the attention of some sharks and hunting dogs that smelled blood. Soon, as the stock price continued to rise, India's Reliance Group and the Tata Group seemed to begin to covet the shares of this pharmaceutical giant that was about to usher in a fortune.

For several consecutive trading days, the stock price continued to rise.

This is definitely not a trend that retail investors can push.

In fact, Adani quickly smelled something was wrong.

Because India's Securities Regulatory Commission department quickly reminded them that Tata Group and Reliance Group were about to get tickets to the board of directors.

As soon as the news came out, Malaysia also immediately noticed something was wrong.

"Mr. Zhou, the current situation is not very good. Sun Pharmaceutical's equity is too dispersed. Although we became the largest shareholder acting in concert on the board of directors, if this trend continues, we cannot rule out Reliance Group and Tata Group. Grab the shares held by other members of the board of directors at high prices..."

"what?"

"You have to make a decision, whether to fight head-on or use some other way to solve the problem..."

"Mr. Adani, it seems you don't have time to prepare this time!"

"Mr. Zhou, I will not touch the shares of Sun Pharmaceuticals without your permission, but the shares I previously held have indeed increased a lot..."

"Mr. Adani, help us with market value management!"

"What did you say?"

"The current stock price has risen too high. I hope to bring the stock price to a low range. We can also take the opportunity to attract more chips, but the premise is..."

"I understand! As long as you allow me, I will be happy to intervene in the stock price issue!"

Zhou Yaojie didn't say anything on the phone, but he and Adani had a tacit understanding.

Immediately afterwards, the stock price continued to rise for several consecutive trading days.

Analysts from all walks of life are optimistic about Sun Pharmaceutical's future development.

But at this moment, Adani's old friend suddenly came forward and publicly responded to the relevant questions about the Indian drug testers.

"Indian lives are precious and cannot be used as guinea pigs for foreign companies to test drugs. Therefore, we will take certain measures in the future to severely crack down on this behavior. This is a serious violation of life!"

At a Hindu rally, Delhi's leading figures publicly spoke out against India's clinical trial system.

Just after this speech was released, the stock price fell.

Many investors who were rushing to raise funds at high positions suddenly lost all their money.

Soon the stock price fell like a stampede.

Adani quickly took advantage of this opportunity to buy another wave of chips.

But when he took action, his opponent was also taking action, and he was playing faster.

But immediately after Indian Pharmaceuticals, a statement broke the illusions of the two giants.

"Due to technical reasons, Indian Pharmaceuticals announced the suspension of research plans for clinical trials with two foreign institutions..."

(End of this chapter)